Your Estradiol Level is Too High and Needs to be Reduced
With a serum estradiol of 1172.4 pg/mL, you are at significantly supraphysiologic levels (nearly 6 times the upper target range) and should reduce your dose immediately to minimize cardiovascular and thromboembolic risks.
Why This Level is Concerning
Your current estradiol concentration far exceeds the recommended therapeutic range of 100-200 pg/mL (or up to 357 pg/mL by some lab reference ranges) 1, 2. At 1172.4 pg/mL, you face increased risks of:
- Venous thromboembolism (VTE) - Trans women on estrogen therapy already have a 2-4 fold increased risk of blood clots, which increases further with supraphysiologic levels 1
- Cardiovascular mortality - Literature shows a 2-4 fold increased risk of cardiovascular death in trans women on hormone therapy 1
- Stroke risk - Elevated estrogen levels increase stroke risk, particularly at supraphysiologic concentrations 1
Immediate Action Required
Reduce your estradiol dose substantially. The specific adjustment depends on your current regimen:
If You're Taking Injectable Estradiol:
- Current guidelines recommend 2-10 mg weekly, but recent evidence shows even these doses often produce supraphysiologic levels 2, 3, 4
- Start at ≤5 mg weekly (or even 3-4 mg weekly), as 78.3% of patients on 3 mg weekly and 76% on 4 mg weekly achieved appropriate levels of 100-357 pg/mL 2
- Injectable estradiol produces the highest serum concentrations compared to oral or transdermal routes 5
- With guideline-concordant injectable doses, 91% of patients had supratherapeutic levels 6
If You're Taking Oral Estradiol:
- Oral estradiol at mean doses of 2.8 mg daily produced mean levels of 168 pg/mL, with only 14% supratherapeutic 6
- Your level suggests you're taking a very high oral dose that needs significant reduction
If You're Taking Transdermal Estradiol:
- This is unlikely given your extremely high level, as transdermal produces the lowest serum concentrations 5
Testosterone Suppression Considerations
The good news: You likely don't need such high estradiol levels for testosterone suppression. Studies show that 83.6% of patients on 3 mg injectable weekly and 90% on 4 mg weekly achieved testosterone <50 ng/dL 2. Adequate testosterone suppression occurs at much lower estradiol levels than what you currently have.
Monitoring Strategy
After dose reduction:
- Recheck estradiol in 4-6 weeks to ensure levels fall into the 100-200 pg/mL range (or up to 357 pg/mL maximum)
- Check testosterone simultaneously to confirm adequate suppression (<50 ng/dL)
- If using injectable estradiol, time your blood draw mid-cycle between injections for accurate assessment 2, 4
Common Pitfall to Avoid
Do not assume higher estradiol levels produce better feminization. There is no evidence that levels above 200 pg/mL provide superior feminizing outcomes 7. The systematic review found no studies demonstrating that the guideline range provides optimal feminization or that higher levels improve results 7. You're exposing yourself to serious cardiovascular and thromboembolic risks without additional benefit.
Route-Specific Considerations
Injectable estradiol consistently produces higher levels than oral or transdermal routes 5, 8. If you're struggling to achieve appropriate levels with injectable therapy, consider switching to oral estradiol, which produces more moderate levels with better dose-response relationships 6, 5.